DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Sun JK, Wang PW, Taylor S. et al.
Durability of diabetic retinopathy improvement with as-needed ranibizumab: open-label extension of RIDE and RISE studies.
Ophthalmology 2019;
126: 712-720
doi:10.1016/j.ophtha.2018.10.041
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.